Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Antidiabetic Biguanides market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Antidiabetic Biguanidesmarket, defines the market attractiveness level of Antidiabetic Biguanides market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Antidiabetic Biguanides industry, describes the types of Antidiabetic Biguanides market, the applications of major players and the market size, and deeply analyzes the current situation of the global Antidiabetic Biguanides market and the development prospects and opportunities of Antidiabetic Biguanides industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Antidiabetic Biguanides market in Chapter 13.
By Player:
Eli Lilly
AstraZeneca
Novo Nordisk
GlaxoSmithKline
Pfizer
Servier Laboratories
Bristol-Myers Squibb
Merck & Co
Boehringer Ingelheim
Takeda Pharmaceuticals
Sanofi
By Type:
Metformin IR
Metformin SR
By End-User:
Hospitals
Clinics
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Antidiabetic Biguanides Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Antidiabetic Biguanides Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Antidiabetic Biguanides Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Antidiabetic Biguanides Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Antidiabetic Biguanides Market Analysis and Outlook to 2022
-
7.1 Global Antidiabetic Biguanides Consumption (2017-2022)
-
7.2 United States Antidiabetic Biguanides Consumption (2017-2022)
-
7.3 Europe Antidiabetic Biguanides Consumption (2017-2022)
-
7.4 China Antidiabetic Biguanides Consumption (2017-2022)
-
7.5 Japan Antidiabetic Biguanides Consumption (2017-2022)
-
7.6 India Antidiabetic Biguanides Consumption (2017-2022)
-
7.7 South Korea Antidiabetic Biguanides Consumption (2017-2022)
8 Region and Country-wise Antidiabetic Biguanides Market Analysis and Outlook to 2028
-
8.1 Global Antidiabetic Biguanides Consumption Forecast (2022-2028)
-
8.2 United States Antidiabetic Biguanides Consumption Forecast (2022-2028)
-
8.3 Europe Antidiabetic Biguanides Consumption Forecast (2022-2028)
-
8.4 China Antidiabetic Biguanides Consumption Forecast (2022-2028)
-
8.5 Japan Antidiabetic Biguanides Consumption Forecast (2022-2028)
-
8.6 India Antidiabetic Biguanides Consumption Forecast (2022-2028)
-
8.7 South Korea Antidiabetic Biguanides Consumption Forecast (2022-2028)
9 Global Antidiabetic Biguanides Market Outlook by Types and Applications to 2022
-
9.1 Global Antidiabetic Biguanides Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Metformin IR Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Metformin SR Consumption and Growth Rate (2017-2022)
-
9.2 Global Antidiabetic Biguanides Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Antidiabetic Biguanides Market Outlook by Types and Applications to 2028
-
10.1 Global Antidiabetic Biguanides Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Metformin IR Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Metformin SR Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Antidiabetic Biguanides Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Antidiabetic Biguanides Import and Export Analysis (Top 5 Countries)
-
11.1 Global Antidiabetic Biguanides Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Antidiabetic Biguanides Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Antidiabetic Biguanides Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Antidiabetic Biguanides Market Competitive Analysis
-
14.1 Eli Lilly
-
14.1.1 Eli Lilly Company Details
-
14.1.2 Eli Lilly Antidiabetic Biguanides Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Eli Lilly Antidiabetic Biguanides Product and Service
-
14.2 AstraZeneca
-
14.2.1 AstraZeneca Company Details
-
14.2.2 AstraZeneca Antidiabetic Biguanides Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 AstraZeneca Antidiabetic Biguanides Product and Service
-
14.3 Novo Nordisk
-
14.3.1 Novo Nordisk Company Details
-
14.3.2 Novo Nordisk Antidiabetic Biguanides Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novo Nordisk Antidiabetic Biguanides Product and Service
-
14.4 GlaxoSmithKline
-
14.4.1 GlaxoSmithKline Company Details
-
14.4.2 GlaxoSmithKline Antidiabetic Biguanides Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GlaxoSmithKline Antidiabetic Biguanides Product and Service
-
14.5 Pfizer
-
14.5.1 Pfizer Company Details
-
14.5.2 Pfizer Antidiabetic Biguanides Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer Antidiabetic Biguanides Product and Service
-
14.6 Servier Laboratories
-
14.6.1 Servier Laboratories Company Details
-
14.6.2 Servier Laboratories Antidiabetic Biguanides Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Servier Laboratories Antidiabetic Biguanides Product and Service
-
14.7 Bristol-Myers Squibb
-
14.7.1 Bristol-Myers Squibb Company Details
-
14.7.2 Bristol-Myers Squibb Antidiabetic Biguanides Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bristol-Myers Squibb Antidiabetic Biguanides Product and Service
-
14.8 Merck & Co
-
14.8.1 Merck & Co Company Details
-
14.8.2 Merck & Co Antidiabetic Biguanides Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Merck & Co Antidiabetic Biguanides Product and Service
-
14.9 Boehringer Ingelheim
-
14.9.1 Boehringer Ingelheim Company Details
-
14.9.2 Boehringer Ingelheim Antidiabetic Biguanides Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Boehringer Ingelheim Antidiabetic Biguanides Product and Service
-
14.10 Takeda Pharmaceuticals
-
14.10.1 Takeda Pharmaceuticals Company Details
-
14.10.2 Takeda Pharmaceuticals Antidiabetic Biguanides Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Takeda Pharmaceuticals Antidiabetic Biguanides Product and Service
-
14.11 Sanofi
-
14.11.1 Sanofi Company Details
-
14.11.2 Sanofi Antidiabetic Biguanides Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Sanofi Antidiabetic Biguanides Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Antidiabetic Biguanides
-
Figure Antidiabetic Biguanides Picture
-
Table Global Antidiabetic Biguanides Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antidiabetic Biguanides Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antidiabetic Biguanides Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Antidiabetic Biguanides Consumption by Country (2017-2022)
-
Figure United States Antidiabetic Biguanides Consumption and Growth Rate (2017-2022)
-
Table Europe Antidiabetic Biguanides Consumption and Growth Rate (2017-2022)
-
Figure China Antidiabetic Biguanides Consumption and Growth Rate (2017-2022)
-
Figure Japan Antidiabetic Biguanides Consumption and Growth Rate (2017-2022)
-
Figure India Antidiabetic Biguanides Consumption and Growth Rate (2017-2022)
-
Figure South Korea Antidiabetic Biguanides Consumption and Growth Rate (2017-2022)
-
Figure Global Antidiabetic Biguanides Consumption Forecast by Country (2022-2028)
-
Figure United States Antidiabetic Biguanides Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Antidiabetic Biguanides Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Antidiabetic Biguanides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Antidiabetic Biguanides Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Antidiabetic Biguanides Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Antidiabetic Biguanides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Metformin IR Consumption and Growth Rate (2017-2022)
-
Figure Global Metformin SR Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Metformin IR Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Metformin SR Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Antidiabetic Biguanides Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Antidiabetic Biguanides Export by Region (Top 5 Countries) (2017-2028)
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Antidiabetic Biguanides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Antidiabetic Biguanides Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Antidiabetic Biguanides Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Antidiabetic Biguanides Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Antidiabetic Biguanides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Antidiabetic Biguanides Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Antidiabetic Biguanides Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Antidiabetic Biguanides Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Antidiabetic Biguanides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Antidiabetic Biguanides Product and Service
-
Table Servier Laboratories (Foundation Year, Company Profile and etc.)
-
Table Servier Laboratories Antidiabetic Biguanides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Servier Laboratories Antidiabetic Biguanides Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Antidiabetic Biguanides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Antidiabetic Biguanides Product and Service
-
Table Merck & Co (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Antidiabetic Biguanides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Antidiabetic Biguanides Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Antidiabetic Biguanides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Antidiabetic Biguanides Product and Service
-
Table Takeda Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceuticals Antidiabetic Biguanides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceuticals Antidiabetic Biguanides Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Antidiabetic Biguanides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Antidiabetic Biguanides Product and Service
-
